ReviewPharmaceuticals (Basel, Switzerland)2020

Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer's Disease and Ischemia-Related Brain Injury.

Michał Wiciński et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.